Have a feature idea you'd love to see implemented?
Let us know!
GOVX GeoVax Labs Inc
Price (delayed)
$1.99
Market cap
$10.47M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$13.2
Enterprise value
$9.06M
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On
Highlights
The quick ratio has plunged by 93% YoY but it has grown by 26% from the previous quarter
GeoVax Labs's net income has decreased by 39% YoY but it has increased by 3.1% from the previous quarter
The equity has dropped by 113% year-on-year
Key stats
What are the main financial stats of GOVX
Market
Valuations
Earnings
Shares outstanding
5.26M
Market cap
$10.47M
Enterprise value
$9.06M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$26.91M
EBITDA
-$26.83M
Free cash flow
-$23.02M
Per share
Balance sheet
Liquidity
EPS
-$13.2
Free cash flow per share
-$9.06
Book value per share
-$1
Revenue per share
$0
TBVPS
$1.61
Total assets
$4.1M
Total liabilities
$6.4M
Debt
$142,292
Equity
-$2.31M
Working capital
-$2.56M
Debt to equity
-0.06
Current ratio
0.6
Quick ratio
0.29
Net debt/EBITDA
0.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-326.9%
Return on equity
-852.6%
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GOVX stock price
How has the GeoVax Labs stock price performed over time
Intraday
-1.97%
1 week
-3.86%
1 month
-38.77%
1 year
-74.55%
YTD
-63.22%
QTD
-17.43%
Financial performance
How have GeoVax Labs's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$27.54M
Net income
-$26.92M
Gross margin
N/A
Net margin
N/A
The operating income has contracted by 39% YoY but it has grown by 2.9% from the previous quarter
GeoVax Labs's net income has decreased by 39% YoY but it has increased by 3.1% from the previous quarter
Growth
What is GeoVax Labs's growth rate over time
Valuation
What is GeoVax Labs stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 14% year-on-year but it rose by 12% since the previous quarter
The equity has dropped by 113% year-on-year
Efficiency
How efficient is GeoVax Labs business performance
The return on equity has dropped by 146% since the previous quarter
The ROA has declined by 47% since the previous quarter
Dividends
What is GOVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GOVX.
Financial health
How did GeoVax Labs financials performed over time
GOVX's total assets is 36% less than its total liabilities
GOVX's total liabilities has surged by 94% since the previous quarter and by 57% year-on-year
The quick ratio has plunged by 93% YoY but it has grown by 26% from the previous quarter
The debt is 106% greater than the equity
The equity has dropped by 113% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.